EPISODE · Jan 26, 2013 · 6 MIN
The Lancet Oncology: January 25, 2013
from Listen to The Lancet Oncology · host The Lancet
John Farley discusses a trial of the MEK inhibitor selumetinib for the treatement of low-grade serous carcinoma of the ovary and peritoneum.
Embed this episode
NOW PLAYING
The Lancet Oncology: January 25, 2013
0:00
6:47
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 6 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on January 26, 2013.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!